Key Board Decisions

A. Bonus Share Issuance

  • Approved issuance of bonus equity shares in ratio of 1:4 (one new fully paid-up bonus equity share for every four existing fully paid-up equity shares)
  • Face value: ₹2 per share
  • Subject to shareholder approval in forthcoming Annual General Meeting
  • Record date for eligibility to be announced later
  • Total number of securities to be issued: 1,03,29,625 shares
  • Bonus shares will be issued out of Securities Premium account and/or retained earnings and/or free reserves and/or any other permitted reserves/surplus available as of March 31, 2026
  • Amount required for implementing bonus issue: ₹2,06,59,250
  • Free reserves/share premium available for capitalization: ₹16,257.78 lakhs (audited figures)
  • Bonus shares to be credited/dispatched within 2 months from Board approval date (on or before November 3, 2026), subject to necessary approvals

Capital Structure Impact (Pre and Post Bonus)

  • Authorized Share Capital: Pre-bonus: ₹10,00,00,000 (5,00,00,000 shares of ₹2 each); Post-bonus: ₹10,40,00,000 (5,20,00,000 shares of ₹2 each)
  • Paid-up Capital: Pre-bonus: ₹8,26,37,000 (4,13,18,500 shares); Post-bonus: ₹10,32,96,250 (5,16,48,125 shares)
  • Subscribed Capital: Pre-bonus: ₹8,26,37,000 (4,13,18,500 shares); Post-bonus: ₹10,32,96,250 (5,16,48,125 shares)

B. Increase in Authorized Share Capital

  • Approved increase in Authorized Share Capital from ₹10,00,00,000 to ₹10,40,00,000
  • Number of equity shares increased from 5,00,00,000 to 5,20,00,000 (face value ₹2 each)
  • Requires amendment to Clause V of Memorandum of Association
  • Subject to shareholder approval in forthcoming AGM and other required approvals

C. Re-appointment of Independent Director

  • Approved re-appointment of Mr. Rohit Jain (DIN: 07191154) as Independent Director for second term of five consecutive years
  • Term: September 30, 2026 to September 29, 2031
  • Subject to shareholder approval
  • Mr. Jain is currently a Partner at Singhania & Co. LLP with over 12 years of professional experience
  • Previous experience includes work with Amarchand & Mangaldas & Suresh A. Shroff & Co., OrthoHeal Pvt. Ltd., Ben & Gaws Private Limited, Shri JJT University, PadUp Ventures, and IIM Calcutta Innovation Park
  • Holds no shares in the company
  • Not related to any other director of the company
  • Not debarred from holding director office by SEBI or any other authority

D. Annual General Meeting

  • 34th Annual General Meeting scheduled for Tuesday, September 29, 2026
  • To be conducted through Video Conferencing/Other AudioVisual Means
  • Annual Report and Notice of AGM to be sent and uploaded on company website

E. Cut-off Date

  • Tuesday, September 22, 2026 fixed as cut-off date for determining members eligible to vote on AGM resolutions

F. Record Date for Dividend

  • Record date for final dividend payment: Tuesday, September 22, 2026
  • Final dividend of ₹0.50 per share recommended by Board on May 30, 2026

G. Book Closure Date

  • Book closure from Wednesday, September 23, 2026 to Tuesday, September 29, 2026 (both days inclusive)

Meeting Details

  • Meeting held on September 3, 2026
  • Commenced at 11:30 AM and concluded at 12:05 PM

Additional Information

  • Information available on company website (www.titanbiotechltd.com) and BSE website (www.bseindia.com)
  • Signed by Charanjit Singh, Company Secretary & Compliance Officer (M.No A12726)